A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels.
A new endoscopically implantable device (SatiSphere) for the treatment of obesity-resistance, safety, and metabolic effects on glucose, insulin and GLP-1 levels